LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Current regulatory landscape for viral point-of-care testing in the United States.

    Shirley, Joshua D / Bennett, Shannon A / Binnicker, Matthew J

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2023  Volume 164, Page(s) 105492

    Abstract: Historically, the diagnosis of viral infections has been accomplished using a combination of laboratory-based methods, including culture, serology, antigen-based tests, and molecular (e.g., real-time PCR) assays. Although these methods provide an ... ...

    Abstract Historically, the diagnosis of viral infections has been accomplished using a combination of laboratory-based methods, including culture, serology, antigen-based tests, and molecular (e.g., real-time PCR) assays. Although these methods provide an accurate way to detect viral pathogens, testing in a centralized laboratory may delay results, which could impact patient diagnosis and management. Point-of-care tests, including antigen- and molecular-based assays, have been developed to assist with the timely diagnosis of several viral infections, such as influenza, respiratory syncytial virus, and COVID-19. Despite the ability of point-of-care tests to provide rapid results (i.e., <30 min), there are issues to consider prior to their routine use, including test performance and specific regulatory requirements. This review will provide a summary of the regulatory landscape of point-of-care tests for viral infections in the United States, and address important considerations such as site certification, training and inspection readiness.
    MeSH term(s) Humans ; United States ; COVID-19/diagnosis ; Molecular Diagnostic Techniques/methods ; Point-of-Care Testing ; Virus Diseases/diagnosis ; Respiratory Syncytial Virus, Human/genetics ; Sensitivity and Specificity ; Point-of-Care Systems
    Language English
    Publishing date 2023-05-17
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2023.105492
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A High-Level Overview of the Regulations Surrounding a Clinical Laboratory and Upcoming Regulatory Challenges for Laboratory Developed Tests.

    Graden, Kevin C / Bennett, Shannon A / Delaney, Sarah R / Gill, Hillary E / Willrich, Maria A V

    Laboratory medicine

    2020  Volume 52, Issue 4, Page(s) 315–328

    Abstract: Objective: Regulations for clinical laboratories in the United States are complex. The goal of this review is to improve the clarity of laboratory-developed test (LDT) regulation to facilitate innovation.: Methods: A literature and regulation review ... ...

    Abstract Objective: Regulations for clinical laboratories in the United States are complex. The goal of this review is to improve the clarity of laboratory-developed test (LDT) regulation to facilitate innovation.
    Methods: A literature and regulation review of current legislation for compliance by U.S. clinical laboratories was performed, and examples of the steps to implement LDTs within compliance with the regulatory environment are shared.
    Results: Many federal and state jurisdictions are critical to the functionality of a laboratory in addition to upcoming potential promulgation of the Verifying Accurate Leading-Edge IVCT Development Act. Increased regulation, although imperative to maintain consistent, high-standard clinical care, could mean additional costs for developers and healthcare while also hindering innovation.
    Conclusion: An extensive discussion of proposed regulations for LDTs needs to occur. Laboratory testing requires the sustained use of innovative methods at a cost that will permit continued, timely, uninterrupted high-quality service.
    MeSH term(s) Clinical Laboratory Services ; Humans ; Laboratories, Clinical ; United States ; United States Food and Drug Administration
    Language English
    Publishing date 2020-12-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 391758-7
    ISSN 1943-7730 ; 0007-5027
    ISSN (online) 1943-7730
    ISSN 0007-5027
    DOI 10.1093/labmed/lmaa086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top